Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc. scores highest on Anchor (70) and lowest on Earnings (19). Its PosiPenta is 45.87 out of 100, around the middle of similar companies.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Details
PPrice
| P/E ratio | -4.39 |
| P/B ratio | 1.75 |
EEarnings
| Trailing EPS | ₹-433.15 |
| Forward EPS | ₹-450.95 |
NNitro
| Price | 1902.28 |
| 52-week high | 3746.74 |
| 52-week low | 1471.02 |
| Fall from 52-week high | 49.2% |
TTorque
| Return on equity (ROE) | -33.80% |
| Debt-to-equity | 0.02 |
AAnchor
| Beta (price swings) | 0.38 |
| Market cap | ₹3,718 Cr |
| Insider holding | 37.60% |
| Dividend yield | 0.00% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Tectonic Therapeutic, Inc.'s PosiPenta score?
Tectonic Therapeutic, Inc.'s PosiPenta is 45.87 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Which PosiPenta pillar is strongest for Tectonic Therapeutic, Inc.?
Anchor (stability and dividends), with a score of 70 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Tectonic Therapeutic, Inc.?
Earnings (growth), with a score of 19 out of 100: much weaker than most similar companies.
Has Tectonic Therapeutic, Inc.'s PosiPenta changed since last week?
Yes, it fell 0.68 points, from 46.55 to 45.87.
PositoAI is for research and education only and is not investment advice.